Dose adjustment in special animal populations or under special therapeutic conditions. Assessing the sources of variability in drug disposition and residue depletion in animal populations through the application of population pharmacokinetic and pharmacodynamic techniques.
Assessment of the risks associated with human exposure to environmental pollutants through the application of physiologically based pharmacokinetic and pharmacodynamic modeling.
Study of the association between drug exposure and the emergence of bacterial resistance in animal populations under different dosage regimen conditions.
Establishing information systems on antimicrobial use and the emergence of bacterial resistance in animal populations in Central America.